2022 annual financial data
Mereo BioPharma Group 2022 Net margin
Direct answer
Net margin was -2,795.09%.
Operating income was -53,667,430 GBP and net income was -42,121,955 GBP.
Operating cash flow was -48,821,000 GBP.
Get free Mereo BioPharma Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,507,000 GBP
- Operating income
- -53,667,430 GBP
- Net income
- -42,121,955 GBP
- Operating cash flow
- -48,821,000 GBP
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Mereo BioPharma Group financial years